MedTrace Logo

Proton Therapy for Lymph Nodes in Breast Cancer

NCT01365845 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-06-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if proton radiation therapy will reduce the amount of heart that is exposed to radiation, thereby decreasing the frequency and/or severity of any cardiac side effects.

Conditions

Interventions

RADIATION

Photon

50.4 Gy to the breast/chest wall and peripheral lymph nodes at 1.8 Gy per fraction

RADIATION

3D-Proton/Conventional plan or 3D-proton only

50.4 Cobalt Gray Equivalent/Gray to the breast/chest wall and peripheral lymph nodes at 1.8 Cobalt Gray Equivalent/Gray per fraction

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Julie A Bradley, MD · University of Florida Proton Therapy Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-03-31
Completion
2018-05-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01365845 on ClinicalTrials.gov